You just read:

Global Neurodegenerative Drugs Market Set to Hit $45 Billion by 2022: High Degree of Failure & Uncertainty within the R&D of Neurodegenerative Disorder Drugs - Research and Markets

News provided by

Research and Markets

Jan 30, 2017, 10:10 ET